Outcomes of Tofacitinib Use in an Irish Pediatric Cohort.
JPGN reports(2023)
摘要
Combining tofacitinib with other biologics is effective in select children with refractory UC. Early responders were more likely to achieve a sustained response at week 16. Failure to achieve remission by week 16 of tofacitinib therapy was strongly associated with progression to colectomy.
更多查看译文
关键词
tofacitinib use,pediatric
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要